Eagle Pharmaceuticals shares owned by Vanguard Group
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.2M | 564k | 5.60 |
| 2024-03-31 | $3.4M | 641k | 5.24 |
| 2023-12-31 | $3.3M | 638k | 5.23 |
| 2023-09-30 | $10M | 644k | 15.77 |
| 2023-06-30 | $12M | 622k | 19.44 |
| 2023-03-31 | $22M | 757k | 28.37 |
| 2022-12-31 | $22M | 764k | 29.23 |
| 2022-06-30 | $34M | 772k | 44.43 |
| 2022-03-31 | $39M | 781k | 49.49 |
| 2021-09-30 | $43M | 763k | 55.78 |
| 2021-06-30 | $32M | 753k | 42.81 |
| 2021-03-31 | $32M | 773k | 41.72 |
| 2020-12-31 | $36M | 765k | 46.59 |
| 2020-09-30 | $31M | 739k | 42.48 |
| 2020-06-30 | $35M | 733k | 47.99 |
| 2020-03-31 | $34M | 740k | 46.00 |
| 2019-12-31 | $46M | 760k | 60.08 |
| 2019-09-30 | $43M | 760k | 56.14 |
| 2019-03-31 | $38M | 756k | 50.50 |
| 2018-12-31 | $29M | 728k | 40.35 |
| 2018-09-30 | $47M | 675k | 69.31 |
| 2018-06-30 | $47M | 616k | 75.67 |
| 2018-03-31 | $31M | 579k | 52.66 |
| 2017-12-31 | $30M | 570k | 53.39 |
| 2017-09-30 | $34M | 566k | 60.00 |
| 2017-06-30 | $44M | 562k | 78.92 |
| 2017-03-31 | $38M | 458k | 82.92 |
| 2016-12-31 | $34M | 429k | 80.00 |
| 2016-09-30 | $29M | 421k | 70.00 |
| 2016-06-30 | $14M | 363k | 38.78 |
| 2015-12-31 | $32M | 359k | 88.68 |
| 2015-09-30 | $43M | 574k | 74.04 |
| 2015-06-30 | $26M | 315k | 80.84 |
| 2015-03-31 | $8.5M | 203k | 42.11 |
| 2014-12-31 | $542k | 35k | 15.51 |
| 2014-09-30 | $420k | 33k | 12.64 |
| 2014-06-30 | $176k | 12k | 14.37 |